QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs
57 views
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately allows in-depth investigations across diverse data-sources (GEO, CPTAC, TCGA, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation.
In this webinar you will learn how to:
• Easily identify relevant samples using extensive manually curated clinical metadata
• Visualize and identify checkpoint inhibition biology related drug target and biomarkers expression patterns in bulk and single cell RNA-seq studies.
• Reveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...
High-quality biomedical relationships knowledge is the cornerstone of modern...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN OmicSoft trainings- 3 part series - Oct 20 (part 1)
In three separate 60-minute trainings, attendees will learn how to use basic...
QIAGEN OmicSoft and Biomedical Knowledge Base
Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021
In this training, users will learn how to generate downstream outputs such...